In contrast to mice, ZBTB20 has also been implicated in the reactivation of AFP in human HCC cells via a microRNA (miR)-122-mediated regulatory axis, in which ZBTB20 acts as a negative regulator of invasive phenotypes [83] (Figure 3A). Here, AFP is linked to hepatocellular carcinoma.